Arthritis Research & Therapy

Table 2 Correlation between MΦ subsets and SF sCD163 and sCD14

From: Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study

	sCD163 (ng/ml)		sCD14 (ug/ml)
	Pearson’s r, CI	Adjusted p	Pearson’s r, CI	Adjusted p
CD14⁺CD16⁺-MΦs/total SF MΦs	−0.007 (− 0.263, 0.232)	1.000	−0.044 (− 0.306, 0.226)	0.996
CD14⁺CD16^neg-MΦs /total SF MΦs	0.009 (− 0.231, 0.250)	1.000	0.073 (− 0.185, 0.318)	0.967
CD14^lowCD16⁺-MΦs /total SF MΦs	− 0.008 (− 0.186, 0.270)	1.000	−0.110 (− 0.300, 0.091)	0.708
Total MΦs/total SFLs	− 0.147 (− 0.334, 0.074)	0.695	−0.304 (− 0.491, − 0.073)	0.028
CD14⁺CD16⁺-MΦs/total SFLs	−0.131 (− 0.329, 0.097)	0.654	−0.294 (− 0.482, − 0.054)	0.043
CD14⁺CD16^neg-MΦs/total SFLs	−0.134 (− 0.328, 0.090)	0.614	−0.225 (− 0.428, 0.000)	0.165
CD14^lowCD16⁺-MΦs/total SFLs	− 0.053 (− 0.218, 0.226)	0.969	−0.223 (− 0.390, − 0.018)	0.111

N = 81. Values in boldface show results with significant effect estimates (β)
MΦ monocytes/macrophages, SF synovial fluid, SFL, synovial fluid leukocytes

Back to article page

ISSN: 1478-6362

Contact us

General enquiries: journalsubmissions@springernature.com